Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Focused Ultrasound-induced Blood-brain Barrier Opening in Alzheimer's Disease
NCT06600880Phase 1Not yet recruiting
- Sponsor
- Columbia University
- Start
- Aug 2027
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Alzheimer's disease (AD), sponsored by Columbia University. Primary endpoint: Total Number of Individuals With Successful Opening of the BBB at 4 days. Planned start Aug 2027; status: not yet recruiting.
02
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06600880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06600880.